Panome Bio Showcases Proteomics Innovation at US HUPO 2026
Panome Bio was proud to exhibit at the US HUPO 2026 Conference, held this February in our home city of St. Louis. Bringing together leaders in proteomics and multi-omics research, US HUPO provided an exciting platform for scientific exchange—and a meaningful opportunity for our team to connect with the community right in our own backyard.
Poster Spotlight: Advancing Proteomics and Multi-Omics Integration
A major highlight of Panome Bio’s presence at US HUPO 2026 was a strong lineup of poster presentations from our R&D team, showcasing innovations across proteomics workflows and integrated multi-omic analysis:
Monday, February 23
Leveraging Paired DDA TMT and DIA LFQ Proteomics Data to Evaluate Platform Performance on Global and PTM-Focused Analyses
Presented by: Ethan Stancliffe, PhD
Tailored Multi-Omic Workflows for Antigen Discovery Across Varied Biological Matrices
Presented by: Sharla Friend
Integrated Multi-Omics Profiling of Serum Reveals Systemic Metabolic Dysregulation in Alzheimer’s Disease
Presented by: Ashima Mehta
Evaluating Nanoparticle-Based Enrichment of Cell Lysates for Automated, Global Proteome Analysis
Presented by: Caitlin Kelly
Tuesday, February 24
Uncovering Novel Biomarkers in Low-Power Studies: A Proteomics-Centric Multi-omics Integration
Presented by: Sandeep Acharya, PhD
These presentations highlighted Panome Bio’s continued focus on improving data quality, expanding proteome coverage, and integrating multiple data types to extract deeper biological insight. From benchmarking advanced acquisition strategies to enabling biomarker discovery in challenging study designs, the work sparked thoughtful discussions with researchers across academia and industry.
Engaging the Proteomics Community
At our booth, the Panome Bio team connected with scientists working in proteomics, translational research, and drug discovery. Many discussions centered on optimizing experimental design, selecting the right combination of omics approaches, and overcoming challenges in complex sample types.
Attendees were particularly interested in how Panome Bio’s streamlined workflows and data analysis pipelines support reproducible, high-resolution proteomics—while also enabling seamless integration with complementary omics layers.
A Home-Field Advantage in St. Louis
Hosting US HUPO in St. Louis made this event especially meaningful for Panome Bio. It was a privilege to welcome colleagues from across the country and around the world to our home city and contribute to a vibrant and collaborative scientific exchange.
We extend our sincere thanks to the organizers of US HUPO and to everyone who visited our booth or attended our poster sessions. We look forward to continuing these conversations and advancing proteomics-driven discovery together in the year ahead.